|
| Press Releases |
|
 |
|
| Tuesday, June 4, 2013 |
|
|
Cytokinetics Announces Publications Relating to Fast Skeletal Troponin Activation in Nemaline Myopathy |
| Cytokinetics, Incorporated (Nasdaq: CYTK) announced the publication of three peer-reviewed manuscripts co-authored by company scientists with a group led by Dr. Henk Granzier, Professor of Physiology, and Norville Endowed Chair, Molecular Cardiovascular Research Program, University of Arizona. more info >> |
|
| Thursday, May 16, 2013 |
|
|
Cytokinetics to Hold Annual Meeting of Stockholders |
| Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that its Annual Meeting of Stockholders will be held on Tuesday, May 22, 2013 at 1:30 PM Pacific Time at the Embassy Suites Hotel, located at 250 Gateway Boulevard in South San Francisco, CA. more info >> |
|
| Wednesday, May 1, 2013 |
|
|
Cytokinetics, Incorporated Reports First Quarter 2013 Financial Results |
| Cytokinetics, Incorporated (Nasdaq: CYTK) reported total research and development revenues of $0.8 million for the first quarter of 2013. more info >> |
|
| Wednesday, April 17, 2013 |
|
|
Cytokinetics to Announce First Quarter Results on April 30, 2013 |
| Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that it is scheduled to report first quarter results on Tuesday, April 30, 2013 at 4:00 PM Eastern Time. Following the announcement, Cytokinetics' senior management will host a conference call at 4:30 PM Eastern Time to discuss operational and financial results and the company's outlook for the future. more info >> |
|
| Thursday, April 4, 2013 |
|
|
Cytokinetics Announces Grant From Families with Spinal Muscular Atrophy for Preclinical Development of Tirasemtiv |
| Cytokinetics, Incorporated (Nasdaq: CYTK) and Families of Spinal Muscular Atrophy (FSMA) announced the award of a grant from FSMA to Cytokinetics to support preclinical research on muscle function in a mouse model of spinal muscular atrophy (SMA) to be conducted with the company's fast skeletal muscle troponin activator, tirasemtiv. Financial details of the grant were not disclosed. more info >> |
|
| Monday, April 1, 2013 |
|
|
Cytokinetics Announces Initiation of First-Time-in-Humans, Phase I Clinical Trial of CK-2127107 |
| Cytokinetics, Incorporated (Nasdaq: CYTK) announced today the initiation of a first-time-in-humans, Phase I clinical trial of CK-2127107 in healthy male volunteers. more info >> |
|
| Saturday, March 30, 2013 |
|
|
Cytokinetics to Present at Upcoming Healthcare Conferences |
| Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that Robert I. Blum, President and Chief Executive Officer, is scheduled to present a corporate update at the following healthcare conferences. more info >> |
|
| Thursday, March 21, 2013 |
|
|
Cytokinetics Announces Presentation of Phase IIA Clinical Trial Data of Tirasemtiv in Patients with Myasthenia Gravis |
| Cytokinetics, Incorporated (Nasdaq: CYTK) announced the presentation yesterday of positive data from a completed Phase IIa "Evidence of Effect" clinical trial of tirasemtiv in patients with generalized myasthenia gravis (MG) during the Emerging Science Program at the 65th Annual Meeting of the American Academy of Neurology. more info >> |
|
| Monday, March 18, 2013 |
|
|
Cytokinetics Announces Update to Heart Failure Program |
| Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that ATOMIC-AHF has completed patient enrollment in its third and final cohort. more info >> |
|
| Thursday, March 14, 2013 |
|
|
Cytokinetics to Present Clinical Trial Data Relating to Tirasemtiv in Patients with Myasthenia Gravis |
| Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that an Emerging Science Session poster presentation relating to tirasemtiv is scheduled to be presented at the 65th Annual Meeting of the American Academy of Neurology to be held March 16-23, 2013 at the San Diego Convention Center in San Diego, CA. more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
CEVA Joins Windrose To Test Long-Haul EV Trucking in China
Jun 28, 2025 01:00 HKT/SGT
|
|
|
"Tang Vogue Beyond the Horizons: A Golden Era of Multicultural Integration and Openness" exhibition opens 
Jun 27, 2025 22:36 HKT/SGT
|
|
|
Prime Minister Paetongtarn Positions Thailand as Regional AI Ethics Leader: Official Launch of AIGPC at the UNESCO Global Forum on the Ethics of AI 2025
Jun 27, 2025 17:00 HKT/SGT
|
|
|
GA-ASI Announces Investment in Dutch Technology Innovator Arceon
Jun 27, 2025 01:00 HKT/SGT
|
|
|
IBI Announces 23-Fold Surge in Net Profit for FY2025
Jun 26, 2025 22:37 HKT/SGT
|
|
|
Wasion Wins Three Major Smart Power Meter Contracts In Emerging Overseas Markets, Total Contract Value Exceeds HK$940 million
Jun 26, 2025 20:58 HKT/SGT
|
|
|
AEON Credit Reported Rebound Growth in 1QFY2025/26, Net Profit Up 31.3% to HK$109.3 million
Jun 26, 2025 20:01 HKT/SGT
|
|
|
Regina Miracle FY25 Net Profit Up by 28.4% to HK$180 Million
Jun 26, 2025 19:19 HKT/SGT
|
|
|
On Its Centennial: The Occasion of Replacing the Kiswa of the Noble Kaaba Embodies the Kingdom of Saudi Arabia's Enduring Care for the Two Holy Mosques
Jun 26, 2025 15:00 HKT/SGT
|
|
|
World's Premier AI Conference, World AI Show - Indonesia 2025, Arrives in Jakarta to Power Southeast Asia's AI Revolution
Jun 26, 2025 12:31 HKT/SGT
|
|
|
Honda Opens "Honda Software Studio Osaka" as New Software Development Operation
Jun 26, 2025 13:30 JST
|
|
|
Honda Issues "Honda ESG Report 2025"
Jun 26, 2025 13:29 JST
|
|
|
Fujitsu's Uvance Wayfinders consulting empowers customers to evolve business foundations leveraging data and AI
Jun 26, 2025 11:00 JST
|
|
|
XCF Global and Continual Renewable Ventures Announce Memorandum of Understanding to Launch New Rise Australia, a SAF and HVO Platform Powered by XCF
Jun 26, 2025 09:30 HKT/SGT
|
|
|
Investing News Network Strengthens Australian Presence with Appointment of Industry Veteran John Phillips
Jun 26, 2025 00:39 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
